Selenium-Containing Agents Acting on Cancer—A New Hope?

Selenium-containing agents are more and more considered as an innovative potential treatment option for cancer. Light is shed not only on the considerable advancements made in understanding the complex biology and chemistry related to selenium-containing small molecules but also on Se-nanoparticles....

Full description

Bibliographic Details
Main Authors: Sabrina Garbo, Silvia Di Giacomo, Dorota Łażewska, Ewelina Honkisz-Orzechowska, Antonella Di Sotto, Rossella Fioravanti, Clemens Zwergel, Cecilia Battistelli
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/15/1/104
_version_ 1827622585141035008
author Sabrina Garbo
Silvia Di Giacomo
Dorota Łażewska
Ewelina Honkisz-Orzechowska
Antonella Di Sotto
Rossella Fioravanti
Clemens Zwergel
Cecilia Battistelli
author_facet Sabrina Garbo
Silvia Di Giacomo
Dorota Łażewska
Ewelina Honkisz-Orzechowska
Antonella Di Sotto
Rossella Fioravanti
Clemens Zwergel
Cecilia Battistelli
author_sort Sabrina Garbo
collection DOAJ
description Selenium-containing agents are more and more considered as an innovative potential treatment option for cancer. Light is shed not only on the considerable advancements made in understanding the complex biology and chemistry related to selenium-containing small molecules but also on Se-nanoparticles. Numerous Se-containing agents have been widely investigated in recent years in cancer therapy in relation to tumour development and dissemination, drug delivery, multidrug resistance (MDR) and immune system-related (anti)cancer effects. Despite numerous efforts, Se-agents apart from selenocysteine and selenomethionine have not yet reached clinical trials for cancer therapy. The purpose of this review is to provide a concise critical overview of the current state of the art in the development of highly potent target-specific Se-containing agents.
first_indexed 2024-03-09T11:28:33Z
format Article
id doaj.art-7dc09047977e45b1a873ba650af1785f
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-09T11:28:33Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-7dc09047977e45b1a873ba650af1785f2023-11-30T23:57:42ZengMDPI AGPharmaceutics1999-49232022-12-0115110410.3390/pharmaceutics15010104Selenium-Containing Agents Acting on Cancer—A New Hope?Sabrina Garbo0Silvia Di Giacomo1Dorota Łażewska2Ewelina Honkisz-Orzechowska3Antonella Di Sotto4Rossella Fioravanti5Clemens Zwergel6Cecilia Battistelli7Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, ItalyDepartment of Physiology and Pharmacology “V. Erspamer”, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, ItalyDepartment of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College in Kraków, Medyczna 9, 30-688 Kraków, PolandDepartment of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College in Kraków, Medyczna 9, 30-688 Kraków, PolandDepartment of Physiology and Pharmacology “V. Erspamer”, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, ItalyDepartment of Drug Chemistry and Technologies, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, ItalyDepartment of Drug Chemistry and Technologies, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, ItalyDepartment of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, ItalySelenium-containing agents are more and more considered as an innovative potential treatment option for cancer. Light is shed not only on the considerable advancements made in understanding the complex biology and chemistry related to selenium-containing small molecules but also on Se-nanoparticles. Numerous Se-containing agents have been widely investigated in recent years in cancer therapy in relation to tumour development and dissemination, drug delivery, multidrug resistance (MDR) and immune system-related (anti)cancer effects. Despite numerous efforts, Se-agents apart from selenocysteine and selenomethionine have not yet reached clinical trials for cancer therapy. The purpose of this review is to provide a concise critical overview of the current state of the art in the development of highly potent target-specific Se-containing agents.https://www.mdpi.com/1999-4923/15/1/104seleniumcancercancer therapyimmunotherapysmall organic Se-containing compoundsSe-nanoparticles
spellingShingle Sabrina Garbo
Silvia Di Giacomo
Dorota Łażewska
Ewelina Honkisz-Orzechowska
Antonella Di Sotto
Rossella Fioravanti
Clemens Zwergel
Cecilia Battistelli
Selenium-Containing Agents Acting on Cancer—A New Hope?
Pharmaceutics
selenium
cancer
cancer therapy
immunotherapy
small organic Se-containing compounds
Se-nanoparticles
title Selenium-Containing Agents Acting on Cancer—A New Hope?
title_full Selenium-Containing Agents Acting on Cancer—A New Hope?
title_fullStr Selenium-Containing Agents Acting on Cancer—A New Hope?
title_full_unstemmed Selenium-Containing Agents Acting on Cancer—A New Hope?
title_short Selenium-Containing Agents Acting on Cancer—A New Hope?
title_sort selenium containing agents acting on cancer a new hope
topic selenium
cancer
cancer therapy
immunotherapy
small organic Se-containing compounds
Se-nanoparticles
url https://www.mdpi.com/1999-4923/15/1/104
work_keys_str_mv AT sabrinagarbo seleniumcontainingagentsactingoncanceranewhope
AT silviadigiacomo seleniumcontainingagentsactingoncanceranewhope
AT dorotałazewska seleniumcontainingagentsactingoncanceranewhope
AT ewelinahonkiszorzechowska seleniumcontainingagentsactingoncanceranewhope
AT antonelladisotto seleniumcontainingagentsactingoncanceranewhope
AT rossellafioravanti seleniumcontainingagentsactingoncanceranewhope
AT clemenszwergel seleniumcontainingagentsactingoncanceranewhope
AT ceciliabattistelli seleniumcontainingagentsactingoncanceranewhope